EQS-News: Immunic AG: Immunic Highlights 2024 Accomplishments and Upcoming Milestones | Issuer: Immunic AG
/ Key word(s): Miscellaneous
Immunic Highlights 2024 Accomplishments and Upcoming Milestones
07.01.2025 / 12:30 CET/CEST
The issuer is solely responsible... ► Artikel lesen |
EQS-News: Immunic AG: Immunic, Inc. to Participate in Investor Conference in December | Issuer: Immunic AG
/ Key word(s): Conference
Immunic, Inc. to Participate in Investor Conference in December
26.11.2024 / 12:30 CET/CEST
The issuer is solely responsible... ► Artikel lesen |
EQS-News: Immunic AG: Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet Gastroenterology & Hepatology | Issuer: Immunic AG
/ Key word(s): Scientific publication
Immunic Announces Publication of Data From Phase 1/1b Clinical Trial of IMU-856 in the Peer Reviewed Journal, The Lancet... ► Artikel lesen |
Xeriant, Inc. Provides Update on Litigation Against XTI Aircraft Co. | BOCA RATON, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Xeriant, Inc. (OTCQB: XERI), an aerospace technology company dedicated to the development and commercialization of advanced materials, announces... ► Artikel lesen |
XTI Aerospace, Inc.: XTI Aerospace to Acquire Equity Interest in ReadyMonitor AI-Powered, Autonomous Drone Company | The Future of Drones is Fully Autonomous
ENGLEWOOD, Colo., Jan. 13, 2025 /PRNewswire/ -- XTI Aerospace, Inc. (NASDAQ: XTIA) ("XTI" or the "Company"), a pioneer... ► Artikel lesen |
XFRA N2T: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILXTI AEROSPACE INC.... ► Artikel lesen |
Applied DNA Sciences, Inc.: Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates | - Signals Start of New Commercialization Phase for LineaRx Subsidiary -- Company Negotiating GMP Supply Agreement -- Company Reaffirms Strategic Restructuring Timeline - STONY BROOK, NY / ACCESSWIRE... ► Artikel lesen |
Applied DNA Sciences, Inc.: Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter | STONY BROOK, NY / ACCESSWIRE / January 8, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced... ► Artikel lesen |
Applied DNA Sciences, Inc.: Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA | - Regulatory Approval Showcases Clinical Advancement of Linea DNA as a Rapid and Effective Means of Producing CAR-T cell Therapies -STONY BROOK, NY / ACCESSWIRE / December 18, 2024 / Applied DNA Sciences... ► Artikel lesen |